Work

Randomized comparison of ponatinib versus imatinib in combination with chemotherapy in patients 55 years of age and older with newly diagnosed ph+ ALL: Molecular response and initial outcome analysis of the EWALL PH03 Study

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-440

Authors: Oliver Ottmann, Tongtong Shi, Kimmo Porkka, Anna Lübking, Emmanuelle Clappier, Yosr Hicheri, Thibaut Leguay, Emilie Lemasle, Sarah Burns, Charlotte Letterme, Catharine Porter, Mia Sydenham, Ian Thomas, Jean-Michel Cayuela, Philippe Rousselot

Institutions: Cardiff University, University of Helsinki, Helsinki University Hospital, Skåne University Hospital, Hôpital Saint-Louis, Institut Paoli-Calmettes, Centre Henri Becquerel, Centre Hospitalier de Versailles

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417018846

Cites:

Cited by: 1

Related to: